Kookjeon Pharmaceutical stock price

국전KRX:307750 · KOSDAQ · Healthcare
₩2,365+0.42%
2026-10-02 close
Loading chart…

Today's signals · MACD bullish cross

Signal details →

Kookjeon Pharmaceutical last closed at ₩2,365 (+0.42%) on 2026-10-02. Signals today: MACD bullish cross. Listed on KOSDAQ. Trailing 12 months PER is -68.9×. Its overall grade ranks 129 of 306 stocks in Healthcare.

About this company

Kookjeon Pharmaceutical last closed at ₩2,365 (+0.42%) on 2026-10-02. Signals today: MACD bullish cross. Listed on KOSDAQ.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B · 129/306

Valuation grade C+

Details →

Dividends

2025 dividend per share · ₩10 · Yield 0.00%

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

  • 배터리·소재 밸류체인에서 주요 고객사로 연결될 가능성이 큰 대형 배터리 기업

  • 삼성SDICustomer

    전지·소재 관련 핵심 고객 후보인 대형 배터리 업체

  • SK온Customer

    전기차 배터리 소재 수요를 이끄는 주요 고객사

Details →
About Kookjeon Pharmaceutical
What technical signals does Kookjeon Pharmaceutical (307750) have?
Kookjeon Pharmaceutical current technical signals: MACD bullish cross.
Is Kookjeon Pharmaceutical a cup-and-handle pattern?
No. Kookjeon Pharmaceutical has no valid Cup signal right now.
What published figures are available for Kookjeon Pharmaceutical?
Market cap: KRW 118.67B. Trailing 12 months PER: -68.9×. Latest quarter PBR: 1.13×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-03 dataset

Turn what you saw on this name into a strategy

Ask Q about Kookjeon Pharmaceutical, or open the plan table on the main site.

From the names you found, through to a scheduled run

Set the conditions and they run at the scheduled time (live orders are not open yet).

See plans ↗

Kookjeon Pharmaceutical notifications

Quantus Signal · live data · not investment advice · Privacy Policy